Biora Therapeutics, Inc.
BIOR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $30 | $88 | $92 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $1 | $7 |
| Inventory | $0 | $0 | $2 | $12 |
| Other Curr. Assets | $3 | $7 | $7 | $15 |
| Total Curr. Assets | $19 | $38 | $98 | $126 |
| Property Plant & Equip (Net) | $3 | $3 | $4 | $18 |
| Goodwill | $6 | $6 | $6 | $6 |
| Intangibles | $0 | $0 | $0 | $4 |
| Long-Term Investments | $3 | $6 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $12 | $15 | $10 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $31 | $54 | $109 | $154 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $9 | $17 |
| Short-Term Debt | $3 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $57 | $19 | $53 | $55 |
| Total Curr. Liab. | $63 | $23 | $62 | $73 |
| LT Debt | $45 | $128 | $126 | $160 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $25 | $4 | $6 | $29 |
| Total NC Liab. | $70 | $133 | $132 | $189 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $0 | $0 |
| Total Liabilities | $133 | $156 | $194 | $261 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$951 | -$827 | -$789 | -$541 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $850 | $725 | $1,407 | $434 |
| Total Equity | -$101 | -$102 | -$85 | -$107 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $31 | $54 | $109 | $154 |
| Net Debt | $32 | $99 | $38 | $68 |